Moreover, targeting TLR2 inhibits the expression of chemokines CCL22, MCP-1 and CCR8 to attenuate the recruitment of suppressive immune cells to the tumor microenvironment [26], [35] and result in an overall reduction of suppressive cytokines in the tumor tissue. The gene discussed is CCL22; the disease is neoplasm.